Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Mulligan

Showing results (351-360 of 529) with videos related to

Pageof 53
Sort By:
Breast Cancer Research and Treatment|July 25, 2013
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude miceLu Wang, Yufeng Xie, Khawaja Ashfaque Ahmed, et al.
Ebiomedicine|October 22, 2023
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyRalf Duerr, Dacia Dimartino, Christian Marier, et al.
Archives of Microbiology & Immunology|May 6, 2024
Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus InoculumMakoto Ibaraki, Lilin Lai, Christopher Huerta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccinationRama S Akondy, Philip L F Johnson, Helder I Nakaya, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
Journal of Virology|June 11, 1992
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell typesM J Mulligan, G V Yamshchikov, G D Ritter, et al.
AIDS (London, England)|February 19, 2016
Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with menColleen F Kelley, Lilin Lai, Chris Ibegbu, et al.
Emerging Infectious Diseases|October 18, 2016
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole BloodKristy O Murray, Rodion Gorchakov, Anna R Carlson, et al.
Journal of the American College of Cardiology|October 2, 2012
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathyFrancisco Leyva, Robin J Taylor, Paul W X Foley, et al.
Journal of Dairy Science|April 22, 2026
The effect of concentrate crude protein concentration and replacing imported feed ingredients with locally grown cereals and faba bean on milk production and nitrogen utilization in grazing dairy cowsK M McCarthy, K M Pierce, Z C McKay, et al.
Pageof 53

Showing results (351-360 of 529) with videos related to

Sort By:
Pageof 53
Breast Cancer Research and Treatment|July 25, 2013
Exosomal pMHC-I complex targets T cell-based vaccine to directly stimulate CTL responses leading to antitumor immunity in transgenic FVBneuN and HLA-A2/HER2 mice and eradicating trastuzumab-resistant tumor in athymic nude miceLu Wang, Yufeng Xie, Khawaja Ashfaque Ahmed, et al.
Ebiomedicine|October 22, 2023
Selective adaptation of SARS-CoV-2 Omicron under booster vaccine pressure: a multicentre observational studyRalf Duerr, Dacia Dimartino, Christian Marier, et al.
Archives of Microbiology & Immunology|May 6, 2024
Blockade Antibody Responses in Human Subjects Challenged with a New Snow Mountain Virus InoculumMakoto Ibaraki, Lilin Lai, Christopher Huerta, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 26, 2015
Initial viral load determines the magnitude of the human CD8 T cell response to yellow fever vaccinationRama S Akondy, Philip L F Johnson, Helder I Nakaya, et al.
Vaccine|April 20, 2001
A Phase I safety and immunogenicity trial of UBI microparticulate monovalent HIV-1 MN oral peptide immunogen with parenteral boost in HIV-1 seronegative human subjectsJ S Lambert, M Keefer, M J Mulligan, et al.
Journal of Virology|June 11, 1992
Cytoplasmic domain truncation enhances fusion activity by the exterior glycoprotein complex of human immunodeficiency virus type 2 in selected cell typesM J Mulligan, G V Yamshchikov, G D Ritter, et al.
AIDS (London, England)|February 19, 2016
Differences in expression of gut-homing receptors on CD4+ T cells in black and white HIV-negative men who have sex with menColleen F Kelley, Lilin Lai, Chris Ibegbu, et al.
Emerging Infectious Diseases|October 18, 2016
Prolonged Detection of Zika Virus in Vaginal Secretions and Whole BloodKristy O Murray, Rodion Gorchakov, Anna R Carlson, et al.
Journal of the American College of Cardiology|October 2, 2012
Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathyFrancisco Leyva, Robin J Taylor, Paul W X Foley, et al.
Journal of Dairy Science|April 22, 2026
The effect of concentrate crude protein concentration and replacing imported feed ingredients with locally grown cereals and faba bean on milk production and nitrogen utilization in grazing dairy cowsK M McCarthy, K M Pierce, Z C McKay, et al.
Pageof 53